The litigation centers on allegations that Ozempic and similar GLP-1 receptor agonist medications, including Wegovy and Mounjaro, cause severe gastrointestinal complications such as gastroparesis, commonly referred to as stomach paralysis
GLP-1 weight loss support at Ideal Protocol combines provider-supported semaglutide and tirzepatide options when clinically appropriate with structured nutrition, weekly coaching, daily text education, body composition tracking, mindset support, and real accountability so you are not trying to figure it out alone
doi: 10.1016/J.FOODCHEM.2014.09.083 16 KalhotraPChittepuVCSROsorio-RevillaGGallardo-VelzquezT
Stay vigilant about portion sizes, as your appetite will likely increase after discontinuing therapy
& Pendergrass, M
Recently, the relationship between GLP-1RAs and NAION has been suggested [6]